Cue Biopharma
CUE
80 hedge funds and large institutions have $39.7M invested in Cue Biopharma in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 6 closing their positions.
632% more call options, than puts
Call options by funds: $769K | Put options by funds: $105K
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
25% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 20
24% more capital invested
Capital invested by funds: $32.1M → $39.7M (+$7.59M)
7% more funds holding
Funds holding: 75 → 80 (+5)
0.07% more ownership
Funds ownership: 1.04% → 1.11% (+0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
+$2.38M |
| 2 |
BlackRock
New York
|
+$500K |
| 3 |
Morgan Stanley
New York
|
+$488K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$185K |
| 5 |
Jane Street
New York
|
+$130K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SMH
Sanders Morris Harris
Houston,
Texas
|
-$713K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$324K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$259K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$140K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$116K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AAG
76
Armstrong Advisory Group
Needham,
Massachusetts
| $317 | – | – | – |
|
|
IA
77
IFP Advisors
Tampa,
Florida
| $264 | +$214 | +3 | New |
|
78
Osaic Holdings
Scottsdale,
Arizona
| $164 | – | – | – |
|
|
FFA
79
Farther Finance Advisors
San Francisco,
California
| $58 | +$71 | +1 | New |
|
80
Nisa Investment Advisors
St. Louis,
Missouri
| $53 | +$71 | +1 | New |
|
|
SMH
81
Sanders Morris Harris
Houston,
Texas
| – | -$713K | -11,540 | Closed |
|
82
Simplex Trading
Chicago,
Illinois
| – | -$53.2K | -744 | Closed |
|
83
American Century Companies
Kansas City,
Missouri
| – | -$50K | -725 | Closed |
|
|
CW
84
Channel Wealth
Santa Barbara,
California
| – | -$35.2K | -510 | Closed |
|
85
Wolverine Trading
Chicago,
Illinois
| – | -$25.6K | -371 | Closed |
|
86
Group One Trading
Chicago,
Illinois
| – | -$12.6K | -176 | Closed |
|
CUE Hedge Fund Activity: Q4 2023 in Review
80 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cue Biopharma (CUE) for Q4 2023, worth a combined $39.7M — up 24% from $32.1M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CUE positions and 6 closed out — a net gain of 5 holders — while 25 added to existing stakes and 20 trimmed.
The largest buyer was Bleichroeder LP, adding an estimated $2.38M. The largest seller was Sanders Morris Harris, exiting entirely with an estimated $713K sold.
- 80 institutional investors held Cue Biopharma (CUE) as of Q4 2023, up from 75 in Q3 2023.
- Funds reported $39.7M of Cue Biopharma stock for Q4 2023, up 24% quarter-over-quarter.
- 11 funds opened new Cue Biopharma positions in Q4 2023 and 6 closed out, a net change of +5 holders.
- The largest Cue Biopharma buyer in Q4 2023 was Bleichroeder LP, an estimated $2.38M added.
- The largest Cue Biopharma seller in Q4 2023 was Sanders Morris Harris, an estimated $713K sold.
Based on aggregated 13F filings for Q4 2023.